USD 17.7 billion
Cell and Gene Therapy Market Size, Share, Growth Analysis, By Therapy Type (Cell Therapy, Gene Therapy), By Therapeutic class (Cardiovascular Disease, Cancer), By Delivery Method, By End-Users, By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35G2300 |
Region:
Global |
Published Date: November, 2024
Pages:
194
|Tables:
96
|Figures:
72
Cell and Gene Therapy Market Insights
Global Cell and Gene Therapy Market size was valued at USD 17.7 billion in 2022 and is poised to grow from USD 20.97 billion in 2023 to USD 81.55 billion by 2031, growing at a CAGR of 18.50% during the forecast period (2024-2031).
Advancements in genetic engineering and growing investments in cell research are projected to primarily augment the demand for cell and gene therapy over the coming years. Increasing use of novel cell therapies and gene therapies to treat various diseases will also create new opportunities for cell and gene therapy companies going forward. Rising emphasis on improving patient care, growing demand for novel treatments and therapies, and surging incidence of chronic diseases are other factors that play a crucial role in cell and gene therapy market growth in the future. Increasing regulatory approvals for novel therapies and rapidly rising popularity of personalized medicine are also expected to offer new business scope for cell and gene therapy companies in the long run. However, high costs of advanced therapies, limited reimbursement, and limited accessibility to novel treatments are slated to be key constraints slowing down cell and gene therapy adoption.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Cancer
Fastest Growth
Cell Therapy
Growth Rate
18.50%
Global Cell and Gene Therapy Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Cell and Gene Therapy Market Segmental Analysis
Global Cell and Gene Therapy Market is segmented by Therapy Type, Therapeutic class, Delivery Method, End-Users, and region. Based on Therapy Type, the market is segmented into Cell Therapy, Stem Cells (T Cells, Dendritic Cells, NK Cells, Tumor Cells), Gene Therapy (Gene Silencing, Cell Replacement, Gene Augmentation, Other Therapies). Based on Therapeutic class, the market is segmented into Cardiovascular Disease, Cancer, Genetic Disorder, Rare Diseases, Oncology, Hematology, Ophthalmology, Infectious Disease, Neurological Disorders, and Others. Based on Delivery Method, the market is segmented into In Vivo, and Ex Vivo. Based on End-Users, the market is segmented into Hospitals, Cancer Care Centers, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Analysis by End User
Hospitals are forecasted to account for a major share of the global cell and gene therapy market. Growing investments in healthcare infrastructure development and rising rate of hospitalization for various disease indications are projected to help this segment maintain its high market share. Rising availability of novel therapies such as cell therapy and gene therapy in hospitals is also expected to help create new opportunities for cell and gene therapy providers across the forecast period and beyond.
Meanwhile, the demand for cell and gene therapy in cancer care centers is projected to surge at a robust pace over the coming years. Growing prevalence of cancer around the world and rising demand for novel treatments for the same are contributing to the rapid growth of this segment. High investments in oncology research and development of novel gene and cell therapies targeted towards cancer treatment will also bolster market development in the future.
Analysis by Therapy Type
Cell therapy is projected to account for a prominent chunk of the global cell and gene therapy market share. Rapidly surging demand for novel treatments and therapies coupled with growing investments in cell research and development are projected to primarily help the dominance of this segment. Significant advancements in stem cell research and growing demand for regenerative medicine will also create new opportunities for cell and gene therapy companies in this segment.
On the other hand, the demand for gene therapies is projected to increase at a robust pace over the coming years. Advancements in gene editing and genomic sequencing technologies are projected to promote the adoption of gene therapies in the long run. Growing awareness regarding benefits of gene therapies and rising availability of the same are also expected to contribute to cell and gene therapy market growth in the future.
Global Cell and Gene Therapy Market By Therapy Type
To get detailed analysis on other segments, Request For Free Sample Report
Cell and Gene Therapy Market Regional Insights
North America is projected to account for a dominant share of the global cell and gene therapy market owing to high investments in medical R&D in this region. High healthcare expenditure, presence of a developed healthcare infrastructure, and rising acceptance of novel therapies are key factors that contribute to the dominance of this region. The United States is slated to be the leading market for cell and gene therapy providers looking to dominate North American market. Supportive government initiatives and funding to boost medical research will also help promote market development in this region.
Meanwhile, the demand for cell and gene therapy in the Asia Pacific region is projected to increase at a robust pace across the study period and beyond. Increasing awareness regarding healthcare and growing prevalence of chronic diseases are primarily boosting the demand for cell and gene therapy in this region. Increasing geriatric population, rising healthcare expenditure, and growing awareness regarding benefits of novel therapies are also playing a crucial role in promoting cell and gene therapy market growth in this region. China, India, and Japan will continue to remain the top markets for cell and gene therapy companies operating in this region.
Global Cell and Gene Therapy Market By Region
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Cell and Gene Therapy Market Dynamics
Drivers
- Advancements in Gene Technologies
Genetic engineering and genome mapping technologies have a come a long way owing to high investments in gene research initiatives. These advancements from the gene world are now being integrated with oncology research to create novel cancer gene therapies thereby driving market growth as well.
Demand for Personalized Medicine
- Rapidly increasing demand for personalized medicine around the world is boosting the adoption of novel cell therapies as they are crucial in targeting specific characteristics of an individual. Cell therapies also help in identifying the efficacy of therapy on an individual to reduce the risk of rejection.
Restraints
- High Costs of Treatment
Getting cell and gene therapy is not possible for every patient as they are quite expensive owing to the use of advanced equipment and extensive development costs. These high costs result in limited accessibility to these advanced therapies for patients around the world and especially hurt market growth in developing countries.
- Limited Reimbursement
Since cell and gene therapies are quite new to the scene, most of these advanced therapies are not covered under medical insurance. Which means the patient has to pay for these expensive treatments out of their own pocket and this impedes adoption for patients with limited spending potential around the world.
Request Free Customization of this report to help us to meet your business objectives.
Cell and Gene Therapy Market Competitive Landscape
Cell and gene therapy providers should focus on increasing the affordability and accessibility of their offerings to maximize business growth in the future. Investing in research to foster innovation will be a key strategy for new as well as established cell and gene therapy companies across the study period and beyond. Targeting emerging markets will also offer good return on investment for all cell and gene therapy providers in the future.
Top Player’s Company Profiles
- Alnylam Pharmaceuticals Inc. (US)
- Amgen Inc. (US)
- Biogen Inc. (US)
- CORESTEM Inc. (US)
- Helixmith Co. Ltd. (South Korea)
- JCR Pharmaceuticals Co. Ltd. (Japan)
- Kolon TissueGene Inc. (South Korea)
- Novartis AG (Switzerland)
- Pfizer Inc. (US)
- Gilead Sciences, Inc. (US)
- Sangamo Therapeutics, Inc. (US)
- Bluebird Bio, Inc. (US)
- Zymeworks Inc. (Canada)
- CRISPR Therapeutics AG (Switzerland)
- Celyad Oncology SA (Belgium)
- Atara Biotherapeutics, Inc. (US)
- Athenex, Inc. (US)
- Bristol Myers Squibb (US)
- Kyowa Kirin (Japan)
- Sanofi (France)
Recent Developments
- In April 2024, Smt. Droupadi Murmu, the President of India announced the launch of India’s first home-grown gene therapy for cancer. The novel therapy was developed through collaboration between IIT Bombay, Tata Memorial Centre and ImmunoACT, thereby taking a step forward in improving cancer treatment in the country.
- In September 2024, a new aseptic micro-connector was launched to cell and gene therapy applications. Colder Products Company (CPC) was behind the launch of this new product aimed at cryopreservation processes used in cell and gene therapies.
- In May 2024, under a collaborative effort of PBL and ProPharma, a new cell factory manufacturing device was launched. This new launch is projected to help promote automation in the process of developing and delivering cell and gene therapies around the world.
Cell and Gene Therapy Key Market Trends
- Demand for Combination Therapies: Popularity of combination therapies is increasing around the world owing to their high efficacy in treating a patient. Cell and gene therapy companies should focus on developing novel combination therapies that combine the benefits of gene and cell therapies to give the best possible treatment for patients suffering from various disease indications.
- Use of Advanced Technologies: Cell and gene therapy companies can explore the use of advanced technologies such as artificial intelligence, machine learning, and deep learning to automate their business and create new opportunities for themselves. Use of these technologies can also fast-track the research and development process as well.
Cell and Gene Therapy Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, advancements in gene technologies and high investments in cell research are projected to bolster cell and gene therapy demand over the coming years. On the contrary, high costs of treatment and limited reimbursement for cell and gene therapies are forecasted to slow down cell and gene therapy market growth going forward. Developed healthcare infrastructure and high healthcare expenditure allow North America to lead the adoption of cell and gene therapy on a global level. Cell and gene therapy companies should focus on the development of combination therapies to maximize their business scope and overcome current challenges.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 17.7 billion |
| Market size value in 2031 | USD 81.55 billion |
| Growth Rate | 18.50% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Cell and Gene Therapy Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Cell and Gene Therapy Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Cell and Gene Therapy Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Cell and Gene Therapy Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Cell and Gene Therapy Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Cell and Gene Therapy Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
